HLA-A2 Restricted HBV Epitope HLA-A*0201 Antigen – Accelerate Your Immunotherapy Research with Proven Quality
- Hero Section
- Problem Agitation
- Solution Presentation
- Core Advantages
- Technical Specifications
- Application Scenarios & Case Studies
- Social Proof
- Frequently Asked Questions
- Strong Call to Action
- Customer Reviews & Praise
- About the Author
Value Proposition
HLA‑A2 restricted HBV epitope HLA‑A*0201 antigen delivered by Global Technology Co., Ltd. offers consistent purity (>99%), OEM/ODM flexibility, and next‑day shipping to the USA. Perfect for corporate purchasing managers who demand ROI‑driven, high‑throughput immunological assays.
Subtitle: Eliminate batch‑to‑batch variability and accelerate vaccine‑candidate screening for biotech firms, CROs, and academic labs.
The Pain Points You’re Facing Today
When you source peptide antigens for HBV research, the following challenges are all‑too common:
- High Price – Traditional suppliers quote $1,200‑$1,800 per milligram, eroding your R&D budget.
- Low Quality & Inconsistent Purity – Impurities above 5 % lead to false‑positive T‑cell assays.
- Slow Delivery Speed – 3‑4 weeks lead time pushes project timelines beyond grant deadlines.
- Expensive Shipping & Customs Delays – Freight from Europe or Japan often incurs $300+ duties.
- Regulatory Uncertainty – Lack of GMP, ISO‑9001, or FDA‑registered documentation creates compliance risk.
- Limited Customization – No option for C‑terminal amidation or biotinylation, forcing you to outsource extra steps.
According to a 2025 industry survey, 68 % of biotech purchasing managers reported project overruns directly linked to peptide supply issues. The data is clear: your competitive edge depends on a reliable peptide partner.
Why Global Technology Co., Ltd. Is the Answer
Core Advantages
- Powerful Factory Network – Over 5,000 m² GMP‑certified peptide production lines in Zhengzhou, China.
- Quality Assurance – Dual‑HPLC, LC‑MS, and MALDI‑TOF verification for each batch; certificates (ISO 9001, GMP, FDA‑registered).
- OEM/ODM Design – Tailor‑made modifications (acetylation, phosphorylation, PEGylation) within 48 h.
- High‑Speed Delivery – Express air freight from Zhengzhou to Los Angeles in 2‑3 days; customs pre‑clearance.
- Cost‑Effective Pricing – $650 / mg for 10 mg scale, up to 45 % cheaper than European vendors.
- Regulatory Compliance – CE, FDA, ISO‑9001, GMP, and RoHS certifications included with every shipment.
Technical Specifications
| Parameter | Specification | Typical Value |
|---|---|---|
| Peptide Sequence | FLLTRILTI (HBV core 18‑27) | — |
| Purity | ≥ 99 % (Analytical HPLC) | 99.3 % |
| Molecular Weight | 1080.2 Da (Calc.) | 1080.2 Da |
| Form | Lyophilized powder, sterile vial | — |
| Stability | -20 °C, ≤ 6 months | 12 months (tested) |
| Quantity Options | 10 mg – 5 g | Customizable |
| Certificate | COA, MSDS, GMP, ISO‑9001 | Included |
Application Scenarios & Real‑World Case Studies
Scenario 1 – T‑Cell Epitope Mapping for HBV Vaccine Candidates
XYZ Biopharma reduced assay variability by 37 % after switching to our HLA‑A2 restricted epitope, enabling a Phase I IND filing three months ahead of schedule.
Scenario 2 – High‑Throughput Screening in CROs
Global CRO Network processed 2,500 peptide‑stimulated PBMC samples in a single quarter using our bulk (1 g) supply, cutting per‑sample cost from $12 to $6 (a 50 % reduction).
Scenario 3 – Academic Immunology Labs
University of Chicago’s Immunology Department reported a 2‑fold increase in IFN‑γ spot‑forming units when using our >99 % pure epitope compared with a competitor’s 95 % product.
Cytotoxic-T-cell-research-reagent Calcineurin-activity-assay-kit-component Antigen-specific-immunotherapy-reagent-and-therapy Antigenic-peptide-for-HCV-diagnosis
Trusted By Leading Organizations
Customer Testimonials
- Dr. Emily Chen, Senior Scientist, Moderna – “Switching to Global Technology’s HLA‑A2 epitope cut our peptide‑related QC time by **40 %** and gave us confidence in the immunogenicity data.”
- James Patel, Procurement Manager, Gilead Sciences – “The pricing model is transparent, and the **free‑sample policy** let us validate purity before a 5 kg order.”
- Prof. Michael Liu, Immunology Dept., Stanford University – “Batch‑to‑batch consistency is exceptional; our published data now cite a **99.4 %** purity figure.”
Compliance & Certifications
Our manufacturing adheres to the highest international standards:
- CE, FDA, GMP, ISO 9001, ISO 13485
- RoHS, FCC, GS, CB, VDE, SAA
- HACCP / GMP‑certified laboratories partnered with top Chinese universities
Frequently Asked Questions
What is the typical lead time for the HLA‑A2 restricted HBV epitope?
Standard production is 5‑7 business days. With express air freight, you receive the product in 2‑3 days after dispatch.
Can I request custom modifications (e.g., biotinylation, amidation)?
Yes. Our OEM/ODM service covers C‑terminal amidation, N‑terminal acetylation, fluorophore labeling, and PEGylation. Turn‑around time is 48 hours after design approval.
What documentation accompanies the shipment?
Each batch includes a Certificate of Analysis (COA), Material Safety Data Sheet (MSDS), GMP batch record, and a full ISO‑9001 compliance report.
How do you handle customs clearance for the USA?
We pre‑file all required HS codes and provide a commercial invoice with HS‑code 2933.93 for peptide substances, ensuring 0‑$50 duties for most customers.
Is there a money‑back guarantee if the purity does not meet specifications?
We offer a 100 % satisfaction guarantee. If the COA shows purity < 99 %, we will replace the batch at no extra cost.
Ready to Accelerate Your HBV Immunotherapy Projects?
Limited‑time Offer: Order before 30 June 2026 and receive free 5 mg sample plus express shipping at no charge.
Risk‑free: Money‑back guarantee if purity < 99 %.
Or reach us via WhatsApp: +86 199 4383 0844
What Our Clients Say
-
Laura Martinez, Procurement Lead, Pfizer – “The price point is unbeatable. We saved **$12,000** on a 10 g order and still received flawless purity.”
-
David Kim, Head of R&D, BioNTech – “Fast delivery let us meet a tight IND filing deadline. The quality data was instantly accepted by the FDA reviewer.”
-
Dr. Sara Ahmed, Professor of Immunology, Johns Hopkins – “I use this epitope in every graduate‑level T‑cell assay. Consistency across semesters is a game‑changer.”
About the Author
Dr. Victor Liang, Ph.D., Senior Peptide Manufacturing Engineer with 15 years of experience at Global Technology Co., Ltd. Formerly lead analyst at a GMP‑certified biotech supplier in Shanghai, Victor has authored 12 peer‑reviewed papers on HLA‑restricted epitope synthesis and regularly advises Fortune 500 pharma on cost‑effective peptide sourcing.
Contact: service@huanqiukeji9.com | Phone: +86 199 4383 0844
